Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page shows revision v3.6.4, replacing v3.6.3, indicating an internal update. The study information and layout remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-28T14:07:27.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3, reflecting a newer version of the study record page. This update signifies ongoing maintenance of the page's documentation.
    Difference
    0.1%
    Check dated 2026-06-30T01:33:25.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now reflects that recruitment has ended by noting 'No longer looking for participants,' signaling no active enrollment for this study. In addition, the page adds help-related links (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label while updating the revision metadata to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-15T19:51:14.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's content or metadata. This change does not modify the substantive study details or results.
    Difference
    0.1%
    Check dated 2026-06-08T15:41:05.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.3 to v3.5.4, signaling a new deployment of the page. This update does not change the trial details or related information.
    Difference
    0.1%
    Check dated 2026-05-18T03:54:36.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    This update changes the ClinicalTrials.gov page’s displayed revision/version from v3.5.0 to v3.5.3, indicating an internal platform release without altering the study information presented.
    Difference
    0.1%
    Check dated 2026-04-26T15:18:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.